SYNOPSIS A 51-year-old patient with haemophilia since childhood (usual (Clark et al, 1973) , is caused in part by the failure of the liver to synthesize clotting factors, aggravated by consump-
The syndrome of fulminant hepatic failure, caused by viral hepatitis or toxic liver damage, is characteristically accompanied by a severe coagulation disturbance. Bleeding, which was the direct cause of death in 35 % of the patients in a recent series (Clark et al, 1973) , is caused in part by the failure of the liver to synthesize clotting factors, aggravated by consumption of these factors in the process of intravascular coagulation (Rake et al, 1970) . Levels of many clotting factors are low with the exception of factor VIII, which may become elevated for reasons not currently known (Meili and Straub, 1970) . The finding that the same elevation of factor VIII could occur in a haemophiliac patient with acute hepatitis was rather unexpected, and in this paper we describe the changes found in the serial coagulation tests during the course of the illness.
Clinical History
The patient, a 51-year-old musician, was found to have haemophilia in childhood. All through his life he had suffered from excessive bleeding from wounds and following dental extractions. There was no family history of the disorder. Two months before the admission with hepatitis, the patient had been ' Eighteen days following admission he developed pain in the buttocks, axilla, and abdomen. As well as large haematomas in the axilla and both gluteal muscles, one in the retroperitoneal area was suspected, his haemoglobin falling from 12 to 6 g/100 ml over a 12-hour period. He was given a six-pint blood transfusion, and there was no further progression of the bleeding.
Coagulation Tests and Factor Assays
Standard methods were used for the one-stage prothrombin time with human brain thromboplastin, partial thromboplastin time with kaolin, and thrombin clotting time (Hardisty and Ingram, 1965) . The results were expressed as a ratio with a normal control. Fibrinogen was estimated gravimetrically (Ingram, 1961) . Serum FR antigen was measured by the human tanned red cell haemagglutination inhibition technique (Merskey et al, 1969) , and circulating plasminogen activator was measured on bovine fibrin plates (Astrup and Mullertz, 1952) . The presence of fibrin strands in the plasma after protamine precipitation was assessed by the serial dilution of protamine sulphate (SDPS) test (Gurewich and Hutchinson, 1971) . The turnover of 1251-labelled fibrinogen was measured on three occasions, as described by Rake et al (1970) . The coagulation activity of factor VIII and of factor IX was measured by the one-stage method of Hardisty and Ingram (1965) . Factor-VIJI-related antigen was measured by the method of Denson (1973 Tytgat, 1971) . This was still slightly raised one month later (30-4 %) but had fallen to within the normal range at six months (23 %). An attempt was made to control the intravascular coagulation during the first six days by the administration of a combination of fresh frozen plasma (300 ml 6-hourly) and heparin given by continuous infusion so as to maintain a level of 0 5 mg/100 ml, as assessed by titration against protamine sulphate (O'Shea et al, 1971) .
At the time of admission with hepatitis, but before the administration of FFP, the factor VIII level was 100%. The next day the factor VIII activity had risen to 217 % following 600 ml of FFP and remained above 200% for two weeks, despite the cessation of replacement therapy at six days. One month later, the activity was still 91 % of normal, but by seven months it had fallen to 23%. Factor-VIII-related antigen was greatly elevated for two months ( (Lewis, 1970) . The rise in factor VIII level observed has not previously been documented to our knowledge in a patient with haemophilia suffering from hepatitis. The possibility that this patient suffered from von Willebrand's disease rather than haemophilia, which could account for the rise in factor VIII levels following infusion of plasma, seems unlikely. No abnormality has been detected in bleeding time or platelet function; no such rise has been observed previously when the patient was given cryoprecipitate. Furthermore, the factor VIII levels were also raised before the start of replacement therapy. The levels of factor VIII measured in this patient by a one-stage technique could have been elevated because of the presence of activated clotting factors in the plasma as a result of disseminated intravascular coagulation, the similar one-stage assay for the measurement of factor IX being much less affected by these activated factors (Niemetz and Nossel, 1969) . However, the factor VIII levels remained elevated for a considerable period when there was no other evidence of intravascular coagulation, and the levels of factor-VIlIrelated antigen were also greatly increased. The factor-VUI-related antigen is present in normal amounts in patients with classical haemophilia, and increases in healthy people are observed following all kinds of stress (Denson, 1973) . The rise observed in the present patient during acute hepatitis might suggest that a similar response to stress could also occur in haemophilia.
Several explanations have been proposed for the rise in factor VIII occurring in patients with fulminant hepatic failure. These include the possibility of increased synthesis, impaired physiological clearance which is normally via the liver, or leakage of factor VIUI from damaged cells (Meili and Straub, 1970 
